GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.
Morgan Stanley Maintains Equal-Weight on Goldman Sachs Group, Lowers Price Target to $356
Morgan Stanley analyst Betsy Graseck maintains Goldman Sachs Group (NYSE:GS) with a Equal-Weight and lowers the price target from $384 to $356.